Claims for Patent: 7,565,248

Summary for Patent: 7,565,248

Title:	Computer system for designing oligonucleotides used in biochemical methods
Abstract:	A method for determining one or a set of optimal reagent oligonucleotide sequences used in a biochemical method for evaluating a target nucleic acid sequence having a target feature by defining a set of exclusion values or ranking values specific to the biochemical method, generating candidate reagent oligonucleotide sequences, evaluating the candidate reagent oligonucleotide sequences against the exclusion or ranking parameters, selecting at least one optimal reagent oligonucleotide sequence for the selected biochemical method as applied to the target nucleic acid sequence.
Inventor(s):	Peterson; Raymond J. (Greenbelt, MD)
Assignee:	Celadon Laboratories, Inc. (College Park, MD)
Application Number:	10/398,445
Patent Claims:	1. A computer implemented method for determining an optimal reagent oligonucleotide sequence for use in a biochemical method for evaluating a target nucleic acid sequence having a target feature, the computer implemented method comprising using a computer programmed to execute each of the following steps: (a) receiving a set of exclusion values and/or ranking values specific to the biochemical method, (b) receiving sequence windows that are within 30 kb of a target feature or encompass the target feature for both the sense and antisense strands of the target nucleic acid sequence, wherein the sequence windows have a start and a stop position, (c) generating candidate reagent oligonucleotide sequences complementary to one or both of the sense and antisense strands of the target nucleic acid sequence within each sequence window by moving the sequence window one base at a time from the start position to the stop position, the reagent oligonucleotide sequences having a length less than or equal to the sequence window, (d) evaluating the candidate reagent oligonucleotide sequences against the exclusion and/or ranking parameters, wherein candidate oligonucleotide sequences that satisfy the exclusion and/or ranking parameters are retained, (e) selecting at least one retained candidate oligonucleotide sequence for use in the selected biochemical method as applied to the target nucleic acid sequence and displaying the retained sequence in a graphical user interface or storing the retained sequence on a computer readable medium. 2. The method of claim 1, further comprising: receiving the target nucleic acid sequence, the sequence having at least one target feature, and receiving a selection of the biochemical method for evaluating the target nucleic acid sequence. 3. The method of claim 1, comprising evaluating candidate oligonucleotide sequences against both exclusion and ranking values. 4. The method of claim 1, comprising generating more than one type of candidate sequences and evaluating the more than one type of sequences, the evaluating comprising evaluating the candidate sequences against compatibility values, and further comprising selecting an optimal set of reagent nucleotides comprising more than one oligonucleotide sequence. 5. The method of claim 1, wherein the generating step comprises stepping the sequence window along an examination region of the target sequence. 6. The method of claim 1, wherein the generating step comprises selecting all possible reagent oligonucleotide sequences within a sequence window. 7. The method of claim 1, wherein a sequence window has a minimum length sufficient to generate candidate reagent oligonucleotides specific for the target nucleic acid sequence. 8. The method of claim 1, comprising: discarding a generated reagent oligonucleotide sequence if it falls outside the range of exclusion constraint values, and saving a generated reagent oligonucleotide sequence if it falls within the exclusion constraint values, and ranking the saved reagent oligonucleotide sequences based on comparison to one or more ranking values thereby providing several reagent oligonucleotide sequences, and selecting from the ranked reagent oligonucleotide sequences optimal reagent oligonucleotide sequences for the selected biochemical method as applied to the target nucleic acid sequence. 9. The method of claim 1 further comprising cataloguing the target nucleic acid sequences together their corresponding optimal reagent oligonucleotide sequences and the corresponding biochemical method in a computer database. 10. A computer readable data storage medium storing computer readable program code for causing a computer to perform the steps of the method in claim 9. 11. The method of claim 1 wherein at least one generated reagent oligonucleotide sequence comprises a sequence complementary to the target feature. 12. The method of claim 1 comprising receiving a plurality of biochemical methods each having evaluation parameters and having exclusion, ranking, and/or compatibility values, and further comprising generating and evaluating candidate sequences for one of the biochemical methods. 13. The method of claim 1 comprising receiving a selection of at least one reagent oligonucleotide sequence from the group consisting of a forward and reverse primer pair and one or more probes. 14. The method of claim 1 wherein the biochemical method is selected from the group consisting of: the polymerase chain reaction, propyneT chemistry, phosphoramadite chemistry, reverse transcriptase-polymerase chain, ReactionNucleotide.TM. Sequencing, the anchor method, the Invader method, the single base extension method, cycle sequencing, cyclical polymerase chain reaction, pyrosequencing, ligation, fluorescent in situ hybridization, allele-specific oligonucleotide hybridization (ASOH), dynamic allele-specific hybridization (DASH), antisense oligonucleotide chemistry, nucleic acid hybrid chemistry, and DNA/RNA repair. 15. The method of claim 1 wherein the evaluation parameters are selected from the group consisting of: OligoTm, BufferMg+, BufferK+, DivalentMultiplier, Oligonucleotide Concentration, AmpliconTm, Amplicon Length, AmpliconGC, OligoLength, OligoGC, OligoMonoNucRunLength, Oligo5EndLinker, Oligo5EndModification, Oligo5EndTail, Oligo5EndAllowedBases, Oligo5EndLeftPosition, Oligo5EndRightPosition, Oligo3EndLinker, Oligo3EndModification, Oligo3EndTail, Oligo3EndAllowedBases, Oligo3EndLeftPosition, Oligo3EndRightPosition, Oligo3EndAnalysisLength, Oligo3EndGPlusC, Oligo3 EndDeltaG, Oligo3EndGCClampLength, OligoAlignMatch, OligoAlignMisMatch, OligoAlignBulgePenalty, OligoAlignMaxBulgeAllowed, OligoHairPinMinStemLength, OligoHairPinMnLoopLength, OligoHairPinScore, OligoHairPinDeltaG, OligoHairPinTm, OligoPairAlignScore, OligoPairAlignDeltaG, OligoPairAlignTm, Oligo3EndPairAlignScore, Oligo3EndPairAlignDeltaG, Oligo3EndPairAlignTm, SequenceFeature5EndBuffer- Length, SequenceFeature3EndBufferLength, SequenceFeaturePosition5End, SequenceFeaturePosition3End, and Library SequenceAlignScore. 16. The method of claim 1 wherein the reagent oligonucleotides have a length between 10 and 50 base pairs. 17. The method of claim 1 wherein the reagent oligonucleotides have a T.sub.m of about 50 to about 80 degrees Celsius. 18. The method of claim 1 wherein the reagent oligonucleotides have a guanine-cytosine content between about 10% to about 90%. 19. The method of claim 1 wherein the reagent oligonucleotides have a maximum secondary structure T.sub.m of about 35 degrees Celsius. 20. The method of claim 1 wherein an exclusion value is that the reagent oligonucleotide sequence does not contain an adenine as the ultimate 3' base. 21. The method of claim 1 wherein an exclusion value is that the reagent oligonucleotide sequence does not contain a guanine as the ultimate 5' base. 22. The method of claim 1 wherein the target nucleic acid sequence is received from a database. 23. The method of claim 1 wherein the target nucleic acid sequence comprises more than one target feature. 24. The method of claim 23 wherein the method steps are repeated until optimal reagent oligonucleotide sequences have been generated for all target features and their corresponding biochemical methods. 25. The method of claim 1 wherein the target feature of the target nucleic acid sequence is selected from the group consisting of: a single nucleotide polymorphism, a multimeric subsequence of the target nucleic acid sequence, a cloning sequence, the entire target nucleic acid sequence, a codon, an exon, an intron, a telomere, a viral sequence, a transposon, a noncoding region, a promoter, an enhancer sequence, an expressed sequence tag, and a sequence tagged site. 26. The method of claim 1 wherein the reagent oligonucleotide sequence is selected from the group consisting of: an amplification primer, a sequencing primer, a sequence specific hybridization probe, an anchor probe, an invader probe, a reporter probe, and an antisense oligonucleotide. 27. A computer readable data storage medium storing computer readable program code for causing a computer to perform the steps of the method in claim 1. 28. The method of claim 1, comprising determining a first oligonucleotide prior to determining other oligonucleotides. 29. The method of claim 1, further comprising receiving target nucleic acid sequences that have multiple alleles. 30. The method of claim 1, comprising selecting oligonucleotides to at least one allele. 31. The method of claim 30, comprising selecting oligonucleotides to multiple alleles. 32. The method of claim 1, comprising selecting multiple target nucleic acid sequences per input sequence. 33. The method of claim 1, wherein the start and stop position are set in relation to the position of the target feature. 34. The method of claim 1, wherein step (b) occurs before step (c). 35. A computer system comprising: a computer having a database storing a plurality of target nucleic acid sequences having at least one target feature; a graphical user interface that permits selection of a said target nucleic acid sequence from said database, selection of a biochemical method for evaluating the selected target nucleic acid sequence and the display of reagent oligonucleotide sequences that satisfy exclusion and ranking parameters of said biochemical method; and a computer-readable data storage medium comprising program code for defining a set of exclusion values and/or ranking values specific to the biochemical method, defining sequence windows that are within 30 kb of a target feature or encompasses the target feature for both the sense and antisense strands of the target nucleic acid sequence, wherein the sequence windows have a start and a stop position, generating candidate reagent oligonucleotide sequences complementary to one or both of the sense and antisense strands of the target nucleic acid sequence within sequence window by moving the sequence window one base at a time from the start position to the stop position, the reagent oligonucleotide sequences having a length less than or equal to the sequence window, evaluating the candidate reagent oligonucleotide sequences against the exclusion and/or ranking parameters, and retaining candidate oligonucleotide sequences that satisfy the exclusion and/or ranking parameters, selecting and displaying at least one retained oligonucleotide sequence for use in the selected biochemical method as applied to the target nucleic acid sequence. 36. The computer system of claim 35, wherein the graphical user interface permits selecting from the displayed reagent oligonucleotide sequence. 37. A process of manufacturing reagent oligonucleotides comprising using reagent oligonucleotide sequences generated by the computer system of claim 35 in a nucleic acid synthesizer to produce the selected reagent oligonucleotides. 38. A kit of a predetermined number of reagent oligonucleotides optimized for a biochemical method used in evaluating a target nucleic acid sequence, the reagent oligonucleotides made by the process of claim 37. 39. The kit of claim 38 wherein the predetermined number is one or more. 40. A method of ordering a kit of reagent oligonucleotides comprising: using a computer system of claim 35, that receives the desired target nucleic acid sequence, wherein the target nucleic acid sequence has at least one target feature, generating a set of reagent oligonucleotide sequences useful in one or more biochemical methods used in evaluating said target nucleic acid sequence, receiving a selection of desired sequences from the set of generated reagent oligonucleotide sequences, outputting the received selection to a device capable of synthesizing a kit of reagent oligonucleotides based on the selected reagent oligonucleotide sequences, and providing instructions to ship said kit of reagent oligonucleotides. 41. The method of claim 40 further comprising receiving payment information into said computer system.

Details for Patent 7,565,248

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2020-10-04
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2020-10-04
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2020-10-04